Current diagnostic criteria identify risk for type 2 diabetes too late.
(2023) The Lancet Diabetes & Endocrinology — Vol. 11, n° 4, p. 224-226 (2023)
Files
2023_Bergman_Lancet_Diabetes_Endocrinol.pdf
Postprint (via University of Helsinki)
Open Access - Adobe PDF
- 164.6 KB
Details
- Authors
- Abstract
- The inadequacy of current diagnostic criteria to detect dysglycaemia earlier in the lengthy trajectory to type 2 diabetes could inadvertently be contributing to the burgeoning prevalence of prediabetes and diabetes. This inadequacy originates from several factors. First, criteria for prediabetes are confusing because of the different glucose threshold concentrations recommended by the American Diabetes Association (ADA) and WHO: although the recommended diagnostic criteria for impaired glucose tolerance are the same, those that define impaired fasting glucose are different. Furthermore, ADA (but not WHO due to lack of evidence) recommends measuring HbA 1c concentrations for detecting prediabetes. [...]
- Affiliations
Citations
Bergman, M., Buysschaert, M., Ceriello, A., Hussain, A., Mohan, V., Sesti, G., & Tuomilehto, J. (2023). Current diagnostic criteria identify risk for type 2 diabetes too late. The Lancet Diabetes & Endocrinology, 11(4), 224-226. https://doi.org/10.1016/S2213-8587(23)00039-6 (Original work published 2023)